OpenAI researcher Miles Wang in talks to launch AI drug discovery startup valued at $2B
TechCrunch
The funding discussions point to investor interest in applying AI to make breakthroughs in life sciences.
Continue reading on the source website
To respect copyrights, we only provide a brief summary. Read the full article on TechCrunch.
Read Full Article